hydroxychloroquine has been researched along with Escherichia coli Infections in 3 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sepsis is an overwhelming systemic inflammatory response for which no satisfactory therapeutic drug is available." | 1.51 | Inhibition of autophagy protects against sepsis by concurrently attenuating the cytokine storm and vascular leakage. ( Chao, CH; Lu, LH; Yeh, TM, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, LH | 1 |
| Chao, CH | 1 |
| Yeh, TM | 1 |
| Flanagan, PK | 1 |
| Chiewchengchol, D | 1 |
| Wright, HL | 1 |
| Edwards, SW | 1 |
| Alswied, A | 1 |
| Satsangi, J | 1 |
| Subramanian, S | 1 |
| Rhodes, JM | 1 |
| Campbell, BJ | 1 |
| Rajagopala, S | 1 |
| Singh, N | 1 |
| Gupta, K | 1 |
| Gupta, D | 1 |
1 review available for hydroxychloroquine and Escherichia coli Infections
| Article | Year |
|---|---|
Pulmonary amyloidosis in Sjogren's syndrome: a case report and systematic review of the literature.
Topics: Adrenal Cortex Hormones; Adult; Amyloidosis; Anti-Bacterial Agents; Antitubercular Agents; Biopsy; E | 2010 |
2 other studies available for hydroxychloroquine and Escherichia coli Infections
| Article | Year |
|---|---|
Inhibition of autophagy protects against sepsis by concurrently attenuating the cytokine storm and vascular leakage.
Topics: Animals; Autophagy; Capillary Permeability; Cytokine Release Syndrome; Cytokines; Endothelium, Vascu | 2019 |
Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D.
Topics: Adult; Animals; Cells, Cultured; Crohn Disease; Cytokines; Drug Therapy, Combination; Enzyme Inhibit | 2015 |